首页> 外文期刊>Macromolecular Research >Paclitaxel-Polyurethane Film for Anti-cancer Drug Delivery: Film Characterization and Preliminary in vivo Study
【24h】

Paclitaxel-Polyurethane Film for Anti-cancer Drug Delivery: Film Characterization and Preliminary in vivo Study

机译:紫杉醇-聚氨酯薄膜用于抗癌药物的递送:薄膜表征和初步体内研究

获取原文
获取原文并翻译 | 示例
           

摘要

Polyurethane (PU) films incorporated with an anti-cancer drag paclitaxel (PTX) were prepared using a solvent casting method for potential applications to stent-based drag delivery and the local treatment of malignant tumors around gastrointestinal stents. The films were examined by scanning electron microscopy (SEM), and PTX micro-aggregates were observed when the drug loading was > 2.7 wt%. The in vitro release study revealed that the amount of drag released from the film was virtually independent and cumulative percentage release was inversely proportional to the drug loading. When plotted against the square root of time, the cumulative percentage release was initially linear, but the fraction of the linear region decreased with increasing drag loading, indicating that diffusion-controlled release is not applicable to the PTX molecules in micro-aggregates. When 1.25% PTX-PU films were placed under pre-existing CT-26 tumors in mice, tumor growth was slowed by an average of 65.5% compared to that in the control group.
机译:使用溶剂浇铸方法制备了结合了抗癌药物紫杉醇(PTX)的聚氨酯(PU)膜,可潜在地应用于基于支架的药物递送和胃肠道支架周围恶性肿瘤的局部治疗。通过扫描电子显微镜(SEM)检查膜,并且当载药量> 2.7wt%时观察到PTX微聚集体。体外释放研究表明,从薄膜释放的药物量实际上是独立的,累积释放百分比与载药量成反比。当相对于时间的平方根作图时,累积释放百分比最初是线性的,但是线性区域的分数随阻力载荷的增加而降低,这表明扩散控制释放不适用于微聚集体中的PTX分子。将1.25%PTX-PU膜置于小鼠预先存在的CT-26肿瘤下时,与对照组相比,肿瘤的生长平均减慢了65.5%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号